Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track will explore the latest findings in the pathophysiology and treatment of Parkinson's disease. Researchers are encouraged to present innovative therapeutic approaches and novel biomarkers.
This session will focus on the application of advanced neuroimaging techniques in understanding movement disorders. Presentations will highlight how imaging can inform diagnosis and treatment strategies.
This track will delve into the interplay between genetic predispositions and environmental influences in the development of movement disorders. Studies addressing gene-environment interactions are particularly welcome.
This session will showcase recent clinical trials aimed at developing new therapies for movement disorders. Participants are encouraged to discuss challenges and successes in trial design and implementation.
This track will examine the neurophysiological mechanisms underlying various movement disorders. Presentations should focus on electrophysiological studies and their implications for treatment.
This session will address the cognitive aspects associated with movement disorders, particularly in Parkinson's disease. Research on the assessment and management of cognitive decline will be highlighted.
This track will emphasize the importance of patient-centered care in the management of movement disorders. Discussions will focus on shared decision-making and the role of patient-reported outcomes.
This session will explore novel rehabilitation strategies for individuals with movement disorders. Presentations may include technology-assisted therapies and multidisciplinary approaches.
This track will investigate the role of neuroinflammation in the pathogenesis of movement disorders. Research highlighting potential anti-inflammatory treatments will be particularly relevant.
This session will focus on the unique challenges associated with diagnosing and treating movement disorders in pediatric populations. Innovative strategies and case studies will be presented.
This track will address the ethical implications of conducting research in the field of neurology, particularly concerning vulnerable populations. Discussions will include informed consent and the use of placebos.